Diamyd Medical AB (publ)
DYMDF
$0.73
$0.000.00%
OTC PK
| 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | |
|---|---|---|---|---|---|
| Revenue | 129.59% | 206.90% | -1.63% | -31.03% | -36.70% |
| Total Other Revenue | -- | -- | -- | -100.00% | -100.00% |
| Total Revenue | 130.77% | 208.62% | 0.00% | -31.43% | -36.94% |
| Cost of Revenue | -2.90% | 6.42% | 7.02% | 3.26% | 4.21% |
| Gross Profit | 9.34% | 0.60% | -7.25% | -4.97% | -7.61% |
| SG&A Expenses | 44.88% | 30.57% | 31.59% | 23.56% | 14.50% |
| Depreciation & Amortization | 30.97% | 23.97% | 21.49% | 16.97% | 15.49% |
| Other Operating Expenses | -37.10% | -31.50% | 1.10% | -220.59% | -22.77% |
| Total Operating Expenses | 34.01% | 26.25% | 29.47% | 35.45% | 46.89% |
| Operating Income | -33.91% | -26.11% | -29.50% | -35.54% | -47.09% |
| Income Before Tax | -32.88% | -24.76% | -16.40% | -27.66% | -41.60% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -32.88% | -24.76% | -16.40% | -27.66% | -41.60% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -32.88% | -24.76% | -16.40% | -27.66% | -41.60% |
| EBIT | -33.91% | -26.11% | -29.50% | -35.54% | -47.09% |
| EBITDA | -34.17% | -26.20% | -29.83% | -36.22% | -48.43% |
| EPS Basic | -3.26% | -2.20% | 0.93% | -11.61% | -20.32% |
| Normalized Basic EPS | -7.57% | -6.85% | -13.95% | -6.60% | -14.99% |
| EPS Diluted | -3.26% | -2.20% | 0.93% | -11.61% | -20.32% |
| Normalized Diluted EPS | -7.57% | -6.85% | -13.95% | -6.60% | -14.99% |
| Average Basic Shares Outstanding | 28.72% | 23.22% | 18.75% | 14.02% | 17.87% |
| Average Diluted Shares Outstanding | 28.72% | 23.22% | 18.75% | 14.02% | 17.87% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |